Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
US-12428482-B2 · Sep 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Gu Xiaoling patents
Gu Xiaoling is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Gu Xiaoling |
| Total patents | 6 |
| First publication | Oct 29, 2020 |
| Latest publication | Sep 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antigen binding molecule specifically binding to rankl and ngf, and medical use thereof
US-2024254245-A1 · Aug 1, 2024 · US
Bifunctional fusion protein and pharmaceutical use thereof
US-2023012428-A1 · Jan 12, 2023 · US
PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
US-11359021-B2 · Jun 14, 2022 · US
Anti-pd-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
US-2022098304-A1 · Mar 31, 2022 · US
Pd-l1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
US-2020339692-A1 · Oct 29, 2020 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Shanghai hengrui pharmaceutical co ltd | 6 |
| Jiangsu Hengrui Medicine Co | 5 |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 6 |
| C07K2317/565 | 6 |
| C07K2317/92 | 6 |
| A61P35/00 | 6 |
| C07K2317/52 | 6 |